Skip to main content
LEGNSector not reported

Legend Biotech Corp - ADR (LEGN) Insider Trading

In the last 90 days, 2 Legend Biotech Corp - ADR (LEGN) insiders reported no open-market purchases and 2 sales totaling $308,550. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Sep 29, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 29, 2026Corazon (Corsee) D. SandersDirectorSale27,370$9.46$258,920
Sep 21, 2026Carlos E SantosChief Financial OfficerSale5,430$9.14$49,630
Jun 30, 2026Patrick John CaseyDirectorSale6,000$14.80$88,800
Jun 25, 2026Ying HuangChief Executive OfficerSale5,566$14.78$82,265

Common questions

LEGN insider trading FAQ

Are LEGN insiders buying or selling?
Over the last 90 days, LEGN insiders were net sellers, reporting $0.00 of open-market purchases and $308,550 of sales.
When was the last LEGN insider purchase?
No open-market insider purchase of Legend Biotech Corp - ADR stock was reported in the last 90 days.
Where does LEGN insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Legend Biotech Corp - ADR officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.